Dose-dependent reduction of myocardial infarct size with the perfluorochemical Fluosol-DA

American Heart Journal

Volumn 120, Issue 5, 1990, Pages 1039-1046

  Rice, Holly E ^a   Virmani, Renu ^a   Hart, Christie L ^a   Kolodgie, Frank D ^a   Farb, Andrew ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOSOL DA;

ANIMAL EXPERIMENT; ARTICLE; HEART INFARCTION; HEART INFARCTION SIZE; HISTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FLUOROCARBONS; MALE; MYOCARDIAL INFARCTION; NEUTROPHILS; RABBITS; SUPPORT, NON-U.S. GOV'T;

EID: 0024999789     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/0002-8703(90)90115-E     Document Type: Article

References (47)

1. Functional improvement of jeopardized myocardium following intracoronary streptokinase infusion in acute myocardial infarction
2. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase
3. Factors involved in salvaging ischemic myocardium: effect of reperfusion of arterial blood
4. Studies of experimental coronary artery reperfusion: effects of infarct size, myocardial function, biochemistry, ultrastructure, and microvascular damage
5. The “no-reflow” phenomenon after temporary coronary occlusion in the dog
6. Myocardial reperfusion: a double-edged sword
7. Fluorocarbons reduce myocardial ischemic damage after coronary occlusion
8. Effect of fluorocarbon exchange transfusion on myocardial infarct size in dogs
9. Effect of perfluorochemical Fluosol-DA on infarct morphology in dogs with permanent coronary artery occlusion
10. Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion
11. Effect of Fluosol-DA on infarct morphology and vulnerability to ventricular arrhythmia
12. Beneficial long-term effect of intracoronary perfluorochemical in infarct size and ventricular function in a canine reperfusion model
13. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals: role of neutrophil activation
14. The effect of perfluorochemical Fluosol-DA (20%) on myocardial infarct healing in the rabbit
15. Perfluorochemical as adjunctive therapy with acute angioplasty (PTCA) in anterior myocardial infarction
16. Effects of potential blood substitutes (perfluorochemicals) on rat liver and spleen
17. Application of perfluorochemicals in human beings: a morphologic report of a human autopsy case with experimental studies using the rabbit
18. Effect of exchange transfusion with an oxygen-carrying resuscitation fluid on the efficacy of penicillin therapy of pneumococcal infection in rats
19. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog
20. The preoperative treatment of severely anemic patients with perfluorochemical oxygen-transport fluid Fluosol-DA
21. Perfluorochemicals. Morphologic changes in infused liver, spleen, lung and kidney of rabbits
22. Leukocyte-endothelial interactions
23. Passive mechanical properties of human leukocytes
24. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog
25. Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle
26. Neutrophil-mediated injury to endothelial cells enhancement by endotoxin and essential role of neutrophil elastase
27. Oxygen radical mediated endothelial damage by complement-stimulated granulocytes
28. Leukocyte-derived metabolites of arachidonic acid in ischemia-induced myocardial injury
29. Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by antiinflammatory drugs
30. Effect of perfluorochemical blood substitute on human neutrophil function
31. Paralysis of phagocytic migration due to an artificial blood substitute
32. Preservation of endothelial cell structure and function by intracoronary perfluorochemical in a canine preparation of reperfusion
33. Effect of intravenous fluorocarbons during and without oxygen enhancement on acute myocardial ischemic injury assessed by measurement of intramyocardial gas tension
34. Low dose intravenous perfluorochemicals reduce infarct size and enhance post-ischemic contractile function by abolishing the no-reflow phenomenon [Abstract]
35. Neutrophil depletion fails to modify myocardial no reflow and functional recovery after coronary reperfusion
36. Influence of leukopenia on collateral flow, reperfusion flow, reflow ventricular fibrillation and infarct size in dogs
37. Some morphologic effects of insert particulate loading on hemopoietic elements in mice
38. Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol-DA 20%
39. The wavefront phenomenon of ischemic cell death. I. Myocardial infarct size vs duration of coronary occlusion in dogs
40. Movement of the necrotic wavefront after coronary artery occlusion in the rabbit
41. Experimental infarcts and the microcirculation
42. 2 on tissue-ATP content in ischemic and infarcted myocardium
43. Perfluorochemical blood substitutes differentially alter human monocyte procoagulant generation and oxidative metabolism